Brain training may ease chemo brain in breast cancer survivors
NCT ID NCT01182506
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a 5-week computer-based memory training program for breast cancer survivors who have memory and attention problems after chemotherapy. Sixty women will be randomly assigned to either the full working memory training or a less challenging version. The goal is to see if the training improves memory test scores and daily function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cogmed Working Memory Training Program (computer-based cognitive training software)
What this could lead to
If it works, this could offer a non-drug way to improve memory and attention in breast cancer survivors after chemotherapy.
What could go wrong
This is a small, early-stage study with only 60 participants. The comparison version is less challenging, so any benefit may be modest. Also, tics may increase during training.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States